Dalbavancin as long-term treatment in Corynebacterium striatum Infections: a literature review.
作者信息
Camara-Rodriguez M, Jover-Diaz F, Delgado-Sánchez E, Infante-Urríos A, Peris-García J
机构信息
Francisco Jover Diaz, Unidad de Enfermedades Infecciosas. Hospital Clínico Universitario San Juan. Alicante. Spain.
出版信息
Rev Esp Quimioter. 2024 Jun;37(3):276-278. doi: 10.37201/req/149.2023. Epub 2024 Mar 27.
Abstract
摘要
相似文献
1
Dalbavancin as long-term treatment in Corynebacterium striatum Infections: a literature review.
Rev Esp Quimioter. 2024 Jun;37(3):276-278. doi: 10.37201/req/149.2023. Epub 2024 Mar 27.
2
Multidrug-Resistant Corynebacterium striatum Associated with Increased Use of Parenteral Antimicrobial Drugs.
Emerg Infect Dis. 2016 Nov;22(11):1908-14. doi: 10.3201/eid2211.160141.
3
Use of vancomycin for the treatment of Corynebacterium xerosis pneumonia.
Clin Infect Dis. 1995 Jul;21(1):223. doi: 10.1093/clinids/21.1.223.
4
Sepsis due to multiply resistant Corynebacterium amycolatum.
Eur J Clin Microbiol Infect Dis. 1996 Jul;15(7):617-8. doi: 10.1007/BF01709376.
5
Corynebacterium jeikeium osteomyelitis successfully treated with teicoplanin.
J Infect. 1997 Nov;35(3):325-6. doi: 10.1016/s0163-4453(97)93916-5.
6
Bacteremia due to high-level daptomycin-resistant Corynebacterium striatum: A case report with genetic investigation.
J Infect Chemother. 2019 Nov;25(11):906-908. doi: 10.1016/j.jiac.2019.04.009. Epub 2019 May 14.
7
Antimicrobial susceptibility pattern of Corynebacterium striatum.
Antimicrob Agents Chemother. 1996 Nov;40(11):2671-2. doi: 10.1128/AAC.40.11.2671.
8
Characteristics of opportunistic species of the Corynebacterium and related coryneforms isolated from different clinical materials.
Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):385-91.
9
Teicoplanin treatment of Corynebacterium JK infection and colonization in an immunocompromised patient before and after marrow transplantation.
J Chemother. 1989 Jul;1(4 Suppl):714-5.
10
Infections caused by antibiotic-resistant Corynebacterium group D2.
Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):337-41. doi: 10.1007/BF01962333.
引用本文的文献
1
Rapid Plasmid-Mediated Acquisition of Erythromycin Resistance via in : A 72-Hour Clinical Evolution.
Infect Drug Resist. 2025 Jul 29;18:3771-3777. doi: 10.2147/IDR.S531265. eCollection 2025.
2
Rising prevalence and drug resistance of in lower respiratory tract infections.
Front Cell Infect Microbiol. 2025 Jan 7;14:1526312. doi: 10.3389/fcimb.2024.1526312. eCollection 2024.
本文引用的文献
1
Expert Opinion on Dose Regimen and Therapeutic Drug Monitoring for Long-Term Use of Dalbavancin: Expert Review Panel.
Int J Antimicrob Agents. 2023 Nov;62(5):106960. doi: 10.1016/j.ijantimicag.2023.106960. Epub 2023 Aug 24.
2
Experience with dalbavancin for long-term antimicrobial suppression of left ventricular assist device infections.
Transpl Infect Dis. 2023 Aug;25(4):e14068. doi: 10.1111/tid.14068. Epub 2023 May 9.
3
Prosthetic Joint Infection Successfully Treated with Long-Term Dalbavancin.
Microorganisms. 2023 Feb 21;11(3):550. doi: 10.3390/microorganisms11030550.
4
Experience in the use of dalbavancin in diabetic foot infection.
Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jun-Jul;40(6):296-301. doi: 10.1016/j.eimce.2022.03.001. Epub 2022 Apr 27.
5
The challenge of antibiotic selection in prosthetic joint infections due to Corynebacterium striatum: a case report.
BMC Infect Dis. 2022 Mar 26;22(1):290. doi: 10.1186/s12879-022-07270-0.
6
Bone and Joint Infection Involving spp.: From Clinical Features to Pathophysiological Pathways.
Front Med (Lausanne). 2021 Jan 21;7:539501. doi: 10.3389/fmed.2020.539501. eCollection 2020.
7
Total Hip and Knee Arthroplasy Prosthetic Joint Infections.
Arthroplast Today. 2020 Apr 23;6(2):163-168. doi: 10.1016/j.artd.2020.03.008. eCollection 2020 Jun.
8
Corynebacterium striatum prosthetic joint infection.
Enferm Infecc Microbiol Clin (Engl Ed). 2019 Aug-Sep;37(7):480-481. doi: 10.1016/j.eimc.2018.05.007. Epub 2018 Jun 11.
9
Septic arthritis in a native knee due to Corynebacterium striatum.
Reumatol Clin (Engl Ed). 2018 Sep-Oct;14(5):301-302. doi: 10.1016/j.reuma.2017.01.013. Epub 2017 Mar 7.
10
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
J Antibiot (Tokyo). 2016 May;69(5):381-7. doi: 10.1038/ja.2015.120. Epub 2015 Dec 2.
Zotero 插件